Geode Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.8M | Buy |
1,254,114
+10,147
| +0.8% | +$192K | ﹤0.01% | 1957 |
|
|
2025
Q4 | $23.4M | Sell |
1,243,967
-53,458
| -4% | -$896K | ﹤0.01% | 1916 |
|
|
2025
Q3 | $18.9M | Sell |
1,297,425
-26,072
| -2% | -$372K | ﹤0.01% | 2029 |
|
|
2025
Q2 | $25.9M | Buy |
1,323,497
+43,074
| +3% | +$765K | ﹤0.01% | 1829 |
|
|
2025
Q1 | $22.7M | Buy |
1,280,423
+46,160
| +4% | +$994K | ﹤0.01% | 1837 |
|
|
2024
Q4 | $26.4M | Buy |
1,234,263
+6,539
| +0.5% | +$159K | ﹤0.01% | 1810 |
|
|
2024
Q3 | $38.3M | Buy |
1,227,724
+32,141
| +3% | +$800K | ﹤0.01% | 1606 |
|
|
2024
Q2 | $18.6M | Buy |
1,195,583
+527
| +0% | +$6.37K | ﹤0.01% | 1964 |
|
|
2024
Q1 | $12.7M | Buy |
1,195,056
+36,100
| +3% | +$361K | ﹤0.01% | 2185 |
|
|
2023
Q4 | $13.9M | Buy |
1,158,956
+50,141
| +5% | +$411K | ﹤0.01% | 2139 |
|
|
2023
Q3 | $7.76M | Buy |
1,108,815
+25,806
| +2% | +$238K | ﹤0.01% | 2410 |
|
|
2023
Q2 | $9.21M | Buy |
1,083,009
+66,479
| +7% | +$554K | ﹤0.01% | 2332 |
|
|
2023
Q1 | $9.29M | Buy |
1,016,530
+34,511
| +4% | +$441K | ﹤0.01% | 2294 |
|
|
2022
Q4 | $11.2M | Buy |
982,019
+45,232
| +5% | +$670K | ﹤0.01% | 2196 |
|
|
2022
Q3 | $15.9M | Buy |
936,787
+13,595
| +1% | +$292K | ﹤0.01% | 1904 |
|
|
2022
Q2 | $19.8M | Buy |
923,192
+2,867
| +0.3% | +$79.5K | ﹤0.01% | 1777 |
|
|
2022
Q1 | $34M | Sell |
920,325
-9,548
| -1% | -$372K | ﹤0.01% | 1523 |
|
|
2021
Q4 | $42.3M | Buy |
929,873
+13,847
| +2% | +$723K | 0.01% | 1433 |
|
|
2021
Q3 | $58M | Buy |
916,026
+20,618
| +2% | +$1.57M | 0.01% | 1150 |
|
|
2021
Q2 | $81.9M | Buy |
895,408
+28,661
| +3% | +$2.28M | 0.01% | 926 |
|
|
2021
Q1 | $59M | Buy |
866,747
+103,319
| +14% | +$8.02M | 0.01% | 1098 |
|
|
2020
Q4 | $55.3M | Buy |
763,428
+62,174
| +9% | +$3.6M | 0.01% | 1030 |
|
|
2020
Q3 | $26.6M | Buy |
701,254
+91,548
| +15% | +$3.09M | 0.01% | 1315 |
|
|
2020
Q2 | $21.6M | Buy |
609,706
+27,997
| +5% | +$797K | ﹤0.01% | 1461 |
|
|
2020
Q1 | $12.7M | Buy |
581,709
+31,500
| +6% | +$706K | ﹤0.01% | 1587 |
|
|
2019
Q4 | $11.9M | Sell |
550,209
-10,798
| -2% | -$248K | ﹤0.01% | 1892 |
|
|
2019
Q3 | $12.7M | Buy |
561,007
+12,542
| +2% | +$347K | ﹤0.01% | 1769 |
|
|
2019
Q2 | $19.7M | Buy |
548,465
+68,094
| +14% | +$2.18M | ﹤0.01% | 1489 |
|
|
2019
Q1 | $15.1M | Buy |
480,371
+80,703
| +20% | +$2.35M | ﹤0.01% | 1610 |
|
|
2018
Q4 | $10M | Buy |
399,668
+42,944
| +12% | +$1.1M | ﹤0.01% | 1787 |
|
|
2018
Q3 | $10.3M | Buy |
356,724
+46,676
| +15% | +$873K | ﹤0.01% | 1895 |
|
|
2018
Q2 | $3.79M | Buy |
310,048
+158,338
| +104% | +$1.82M | ﹤0.01% | 2495 |
|
|
2018
Q1 | $1.21M | Buy |
151,710
+21,684
| +17% | +$134K | ﹤0.01% | 3035 |
|
|
2017
Q4 | $954K | Buy |
130,026
+86,887
| +201% | +$542K | ﹤0.01% | 3123 |
|
|
2017
Q3 | $159K | Hold |
43,139
| – | – | ﹤0.01% | 3720 |
|
|
2017
Q2 | $47K | Hold |
43,139
| – | – | ﹤0.01% | 3968 |
|
|
2017
Q1 | $60K | Hold |
43,139
| – | – | ﹤0.01% | 3916 |
|
|
2016
Q4 | $116K | Hold |
43,139
| – | – | ﹤0.01% | 3759 |
|
|
2016
Q3 | $153K | Buy |
43,139
+28,027
| +185% | +$129K | ﹤0.01% | 3679 |
|
|
2016
Q2 | $65K | Hold |
15,112
| – | – | ﹤0.01% | 3884 |
|
|
2016
Q1 | $74 | Hold |
15,112
| – | – | ﹤0.01% | 3899 |
|
|
2015
Q4 | $96K | Hold |
15,112
| – | – | ﹤0.01% | 3894 |
|
|
2015
Q3 | $63K | Buy |
+15,112
| New | +$99.9K | ﹤0.01% | 3979 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
Geode Capital Management's CDNA Position: Q1 2026 in Review
Geode Capital Management increased its CareDx (CDNA) stake by 0.82% in Q1 2026, buying an estimated $192K and bringing the position to 1,254,114 shares worth $21.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1957.
Geode Capital Management first reported a position in CDNA in Q3 2015 and has held it in 43 quarters since. The position peaked at $81.9M in Q2 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Geode Capital Management held 1,254,114 shares of CareDx worth $21.8M as of Q1 2026.
- Geode Capital Management bought 10,147 CareDx shares in Q1 2026, an estimated $192K.
- CareDx made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1957 holding.
- Geode Capital Management first reported a position in CareDx in Q3 2015 and has held it in 43 quarters since.
- Geode Capital Management's CareDx position peaked at $81.9M in Q2 2021.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.